Riskpilot← Back to searchSign inGet full accessNORAMIX LIAMYRANE 4 AS
ASActiveOrg 988443247Liamyrane 13, 5132 NyborgRental and operating of own or leased real estate · NACE 6820Est. 20050 employees
Revenue 2024
NOK 18,9M
+6% vs 2023
EBITDA margin
89.3%
+11% vs 2023
Equity ratio
79.3%
Financial strength
Net profit 2024
NOK 9,8M
+18% vs 2023
| Revenue | NOK 18,9M | +6% |
| EBITDA | NOK 16,9M | +11% |
| Net profit | NOK 9,8M | +18% |
| Total assets | NOK 120,1M | -5% |
| Equity | NOK 95,3M | -1% |
| Employees | 0 | — |
Legal name
NORAMIX LIAMYRANE 4 AS
Org number
988443247
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
16. august 2005
Share capital
NOK 630 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Investere i fast eiendom eller selskaper som eier fast eiendom, og alt som dermed står i forbindelse.
Address
Liamyrane 13, 5132 Nyborg
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 15 886 | 15 891 | 16 780 | 17 833 | 18 946 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | 13 791 | 13 486 | 14 408 | 15 266 | 16 920 |
| Depreciation & amort. | −3 103 | −3 194 | −3 178 | −3 172 | −3 080 |
| EBIT | 10 689 | 10 292 | 11 230 | 12 094 | 13 840 |
| Net financials | −1 314 | −1 096 | −812 | −1 386 | −1 232 |
| Profit before tax | 9 374 | 9 197 | 10 418 | 10 708 | 12 608 |
| Tax | 2 062 | 2 023 | 2 292 | 2 356 | 2 774 |
| Net profit | 7 312 | 7 173 | 8 126 | 8 352 | 9 834 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 132 686 | 129 484 | 126 422 | 125 989 | 120 149 |
| Equity | 90 452 | 97 625 | 96 868 | 96 049 | 95 252 |
| Long-term debt | 1 644 | 1 449 | 15 274 | 16 622 | 780 |
| Short-term debt | 40 589 | 30 410 | 14 279 | 13 318 | 24 117 |
| Total debt | 42 234 | 31 859 | 29 553 | 29 940 | 24 896 |
EBITDA margin
89.3%
This company
15.8%
Market median
+465% vs market
20202024
Equity ratio
79.3%
This company
38.2%
Market median
+108% vs market
20202024
Return on equity
10.3%
This company
18.4%
Market median
+44% vs market
20202024
Net profit margin
51.9%
This company
8.1%
Market median
+541% vs market
20202024
Asset turnover
0.16×
This company
1.12×
Market median
-86% vs market
20202024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KR Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (1) | ||
TE Chief Executive Officer | Chief Executive Officer | 2017 – 2022 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Noramix Invest AsNoramix Eiendom Holding AsNoramix Eiendom Ii As
NORAMIX LIAMYRANE 4 AS (this company)Board members of NORAMIX LIAMYRANE 4 AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Espeseth Rasmussen | Chief Executive Officer | 0 companies |
| Keerthivarman Rasamanickam | Chief Executive Officer | 0 companies |